Los Angeles Capital Management LLC Black Diamond Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

  • $24.2 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022
SELL
$1.5 - $3.63 $133,330 - $322,659
-88,887 Closed
0 $0
Q1 2022

May 06, 2022
BUY
$2.66 - $5.61 $92,115 - $194,274
34,630 Added 63.83%
88,887 $246,000
Q3 2021

Nov 08, 2021
SELL
$8.46 - $12.42 $43,315 - $63,590
-5,120 Reduced 8.62%
54,257 $459,000
Q2 2021

Aug 05, 2021
BUY
$12.19 - $28.17 $723,805 - $1.67 Million
59,377 New
59,377 $724,000

Others Institutions Holding BDTX

# of Institutions
94
Shares Held
47.6M
Call Options Held
2.9K
Put Options Held
69.4K
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $68.3M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email